Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Adial Pharmaceuticals Inc
ADIL
Healthcare
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of treatments for addictions and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients. AD04 is...
investigated in the Company’s ONWARD pivotal Phase III clinical trial for the treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Company’s companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ADIL)
New Post
View:
Posts & Comments
Threaded Posts
(271)
•••
whytestocks
X
Post by
whytestocks
on Sep 04, 2024 3:17pm
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th
BREAKING NEWS: $ADIL Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGLEN ALLEN, Va., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Aug 14, 2024 9:50pm
Adial Pharmaceuticals Reports Second Quarter 2024 Financial
News; $ADIL Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateGLEN ALLEN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 31, 2024 9:37am
BUY BUY BUY BUY BUY
Told ya
(271)
•••
whytestocks
X
Post by
whytestocks
on Jul 24, 2024 5:32pm
3 Tips for Building a Penny Stocks Watchlist
JUST IN: $ADIL 3 Tips for Building a Penny Stocks Watchlist2024-07-24 06:29:00 ET 3 Top Tips for Building a Penny Stocks Watchlist Investing in penny stocks can offer exciting opportunities for
...more
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 23, 2024 9:29am
BUY BUY BUY BUY BUY
Will pop to 3$
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 10, 2024 11:57am
RE:RE:ADIL...early a.m runner on watch after NR
Now at $1.86....Cheers !
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 10, 2024 11:19am
RE:ADIL...early a.m runner on watch after NR
Now at $1.91
(271)
•••
whytestocks
X
Post by
whytestocks
on Apr 10, 2024 10:45am
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Wednesda
News; $ADIL Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Wednesday Morning's Most Active StocksAdial Pharmaceuticals, Inc. (NASDAQ: ADIL) is one today's most active stocks by volume. So
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 10, 2024 9:37am
ADIL...early a.m runner on watch after NR
Don't get married to this....JMHO Already ran weeks ago ; ) Currently at $2.49
(271)
•••
whytestocks
X
Post by
whytestocks
on Feb 28, 2024 2:45pm
S&P 500 Edges Lower; ADT Posts Upbeat Earnings | Benzinga
News; $ADIL S&P 500 Edges Lower; ADT Posts Upbeat Earnings | BenzingaU.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday.The Dow
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Feb 28, 2024 1:45pm
Why is (NASDAQ:VTVT) up more than 100%?
Breaking News: $ADIL Why is (NASDAQ:VTVT) up more than 100%?2024-02-28 13:40:18 ET February 28, 2024, Denver Col, 247marketnews.com Low float stocks continue to grant investors huge wins. Shares of
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Feb 28, 2024 10:15am
Adial Pharmaceuticals Awarded New Patent from the United Sta
News; $ADIL Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office | BenzingaCHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities